Risk prediction for liver injury in Epstein-Barr virus infection in pediatric respiratory tract infections.
Children
Epstein-Barr virus
Infection
Liver injury
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
11 Oct 2023
11 Oct 2023
Historique:
received:
22
07
2023
accepted:
04
10
2023
medline:
1
11
2023
pubmed:
12
10
2023
entrez:
11
10
2023
Statut:
epublish
Résumé
Epstein-Barr virus (EBV) infection is likely to co-occur in pediatric respiratory tract infections (RTIs). Liver injury is the common complication of EBV infection. The detailed risk factors for liver injury in EBV infection remain elusive. We aimed to investigate the incidence, characteristics and potential risk factors for liver injury in EBV infection for early risk prediction. We retrospectively recruited the pediatric RTIs cases with EBV infection according to a predefined criteria from our hospital between January 2015 and December 2017. We extracted the clinical and laboratory data from the electronical medical records. The impact of age, gender, and various parameters on the liver injury risk was investigated. Univariate logistic regression analysis was performed to analyse the association between clinical/laboratory parameters and liver injury. The related indexes were enrolled in the multivariate logistic regression analysis. Decision curve analysis was used to yield the value of related parameters in predicting liver injury. Receiver operating curve (ROC) analysis was applied to produce the C-index of white blood cell (WBC) count for liver injury. We also tested the non-linear association between WBC count and alanine aminotransferase (ALT). A total of 216 pediatric RTIs with EBV infection were enrolled. EBV infection is more likely to occur during the winter season. Cytomegalovirus infection was independently associated with liver injury in EBV infection (OR = 6.972, 95% CI = 1.648-29.490, p = 0.008). WBC count was independently associated with liver injury in EBV infection (OR = 1.169, 95% CI = 1.051-1.301, p = 0.004). The P interaction value between WBC count and cytomegalovirus was 0.149. The decision curve analysis showed that WBC count had larger area under curve compared with platelet (PLT) and birthweight (BW). ROC analysis yielded the c-index of WBC count: 0.75 and cut-point of 8.3. The turning point of WBC count in its association with ALT was 16.8. The p value before and after the turning point was < 0.001 and 0.123, respectively. Cytomegalovirus co-infection demonstrated 5.972 more times of liver injury risk in EBV infection. WBC count was an independent biomarker for liver injury before the turning point of 16.8 in EBV infection. More attention should be paid to the risk of EBV infection in the winter. Cytomegalovirus infection and WBC count merit attention in the monitoring of possible liver injury in EBV infection among pediatric RTIs.
Sections du résumé
BACKGROUND
BACKGROUND
Epstein-Barr virus (EBV) infection is likely to co-occur in pediatric respiratory tract infections (RTIs). Liver injury is the common complication of EBV infection. The detailed risk factors for liver injury in EBV infection remain elusive. We aimed to investigate the incidence, characteristics and potential risk factors for liver injury in EBV infection for early risk prediction.
METHODS
METHODS
We retrospectively recruited the pediatric RTIs cases with EBV infection according to a predefined criteria from our hospital between January 2015 and December 2017. We extracted the clinical and laboratory data from the electronical medical records. The impact of age, gender, and various parameters on the liver injury risk was investigated. Univariate logistic regression analysis was performed to analyse the association between clinical/laboratory parameters and liver injury. The related indexes were enrolled in the multivariate logistic regression analysis. Decision curve analysis was used to yield the value of related parameters in predicting liver injury. Receiver operating curve (ROC) analysis was applied to produce the C-index of white blood cell (WBC) count for liver injury. We also tested the non-linear association between WBC count and alanine aminotransferase (ALT).
RESULTS
RESULTS
A total of 216 pediatric RTIs with EBV infection were enrolled. EBV infection is more likely to occur during the winter season. Cytomegalovirus infection was independently associated with liver injury in EBV infection (OR = 6.972, 95% CI = 1.648-29.490, p = 0.008). WBC count was independently associated with liver injury in EBV infection (OR = 1.169, 95% CI = 1.051-1.301, p = 0.004). The P interaction value between WBC count and cytomegalovirus was 0.149. The decision curve analysis showed that WBC count had larger area under curve compared with platelet (PLT) and birthweight (BW). ROC analysis yielded the c-index of WBC count: 0.75 and cut-point of 8.3. The turning point of WBC count in its association with ALT was 16.8. The p value before and after the turning point was < 0.001 and 0.123, respectively.
CONCLUSIONS
CONCLUSIONS
Cytomegalovirus co-infection demonstrated 5.972 more times of liver injury risk in EBV infection. WBC count was an independent biomarker for liver injury before the turning point of 16.8 in EBV infection. More attention should be paid to the risk of EBV infection in the winter. Cytomegalovirus infection and WBC count merit attention in the monitoring of possible liver injury in EBV infection among pediatric RTIs.
Identifiants
pubmed: 37821886
doi: 10.1186/s13052-023-01546-0
pii: 10.1186/s13052-023-01546-0
pmc: PMC10568893
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
138Informations de copyright
© 2023. Società Italiana di Pediatria.
Références
Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol. 2018;102:84–92.
doi: 10.1016/j.jcv.2018.03.001
pubmed: 29525635
Smatti MK, Yassine HM, AbuOdeh R, AlMarawani A, Taleb S, Althani A, et al. Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar. PLoS One. 2017;12(12):e0189033.
doi: 10.1371/journal.pone.0189033
pubmed: 29228016
pmcid: 5724864
Zhang W, Chen B, Chen Y, Chamberland R, Fider-Whyte A, Craig J, et al. Epstein-Barr virus-associated acute liver failure present in a 67-year-old immunocompetent female. Gastroenterology Res. 2016;9(4–5):74–8.
doi: 10.14740/gr718e
pubmed: 27785330
pmcid: 5040549
Teow SY, Yap HY, Peh SC. Epstein-Barr virus as a promising immunotherapeutic target for nasopharyngeal carcinoma treatment. J Pathog. 2017;2017:7349268.
doi: 10.1155/2017/7349268
pubmed: 29464124
pmcid: 5804410
Jons D, Sundström P, Andersen O. Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis. Acta Neurol Scand. 2015;131(2):69–79.
doi: 10.1111/ane.12294
pubmed: 25208981
Ozgurhan G, Ozcetin M, Vehapoglu A, Karakaya Z, Aygun F. Acute kidney injury complicated Epstein-Barr virus infection in infancy. Case Rep Pediatr. 2015;2015:848959.
pubmed: 26064752
pmcid: 4434190
Kofteridis DP, Koulentaki M, Valachis A, Christofaki M, Mazokopakis E, Papazoglou G, Samonis G. Epstein Barr virus hepatitis. Eur J Intern Med. 2011;22(1):73–6.
doi: 10.1016/j.ejim.2010.07.016
pubmed: 21238898
Schechter S, Lamps L. Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis. Arch Pathol Lab Med. 2018;142(10):1191–5.
doi: 10.5858/arpa.2018-0208-RA
pubmed: 30281361
Shah J, Lingiah V, Pyrsopoulos N, Galan M. Acute liver injury due to severe Epstein-Barr virus infection. ACG Case Rep J. 2020;7(2):e00325.
doi: 10.14309/crj.0000000000000325
pubmed: 32309513
pmcid: 7145184
Xu JH, Yu YY, Xu XY. Clinical features of Epstein-Barr virus infection associated to liver injury in adolescents and adults. Zhonghua Gan Zang Bing Za Zhi. 2021;29(10):915–8.
pubmed: 34814383
Bernal KDE, Whitehurst CB. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Res. 2023;334:199157.
doi: 10.1016/j.virusres.2023.199157
pubmed: 37364815
pmcid: 10292739
Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol. 2022;148(1):31–46.
doi: 10.1007/s00432-021-03824-y
pubmed: 34705104
Draborg AH, Duus K, Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol. 2013;2013:535738.
doi: 10.1155/2013/535738
pubmed: 24062777
pmcid: 3766599
Wang CQ, He J. Ubiquitous distribution of Epstein-Barr virus and the highly uneven distribution of Nasopharyngeal Carcinoma. Chin Med J. 2016;129(20):2506–7.
doi: 10.4103/0366-6999.191827
pubmed: 27748347
pmcid: 5072267
Arjunaraja S, Angelus P, Su HC, Snow A. Impaired control of Epstein-Barr virus infection in B-Cell expansion with NF-κB and T-cell anergy disease. Front Immunol. 2018;9:198.
doi: 10.3389/fimmu.2018.00198
pubmed: 29472930
pmcid: 5809398
Hanlon P, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther. 2014;16(1):R3.
doi: 10.1186/ar4429
pubmed: 24387619
pmcid: 3978841
Hu JH, Zhang XL, Yu GD, Cai H, Gu JQ, Hu ML, Xiang DR, Lian JS, Yu L, Jia HY, Zhang YM, Yang YD. Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosis. BMC Gastroenterol. 2019;19(1):94.
doi: 10.1186/s12876-019-1021-1
pubmed: 31215410
pmcid: 6582562
Moreira A, Mortatti AL, Arruda AF, Freitas C, de Arruda M, Aoki M. Salivary IgA response and upper respiratory tract infection symptoms during a 21-week competitive season in young soccer players. J Strength Cond Res. 2014;28(2):467–73.
doi: 10.1519/JSC.0b013e31829b5512
pubmed: 24473469
Shi T, Huang L, Chen Z, Tian J. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou. China J Med Virol. 2021;93(8):5048–57.
doi: 10.1002/jmv.26941
pubmed: 33719067
Kitamura W, Fujiwara H, Matsumura A, Higaki T, Shibata R, Toji T, Fujii S, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Yoshino T, Maeda Y. Chronic active Epstein-Barr virus infection presenting as refractory chronic sinusitis. Int J Hematol. 2022;116(1):139–45.
doi: 10.1007/s12185-022-03306-y
pubmed: 35157240
Nadeem A, Suresh K, Awais H, Waseem S. Epstein-Barr Virus Coinfection in COVID-19. J Investig Med High Impact Case Rep. 2021;9:23247096211040624.
pubmed: 34428954
pmcid: 8392798
Liu M, Wang R, Xie Z. T cell-mediated immunity during Epstein-Barr virus infections in children. Infect Genet Evol. 2023;112:105443.
doi: 10.1016/j.meegid.2023.105443
pubmed: 37201619
Farrington L, Vance H, Rek J, Prahl M, Jagannathan P, Katureebe A, et al. Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children. Malar J. 2017;16(1):499.
doi: 10.1186/s12936-017-2148-6
pubmed: 29284469
pmcid: 5747142
Ge X, Guo Y, Chen J, Hu R, Feng X. Epidemiology and Seasonality of Respiratory Viruses Detected from Children with Respiratory Tract Infections in Wuxi, East China. Med Sci Monit. 2018;24:1856–62.
doi: 10.12659/MSM.908483
pubmed: 29599424
pmcid: 5892462
Hsu JY, Tsai CC, Tseng KC. Fulminant hepatic failure and acute renal failure as manifestations of concurrent Q fever and cytomegalovirus infection: a case report. BMC infect Dis. 2014;14:651.
doi: 10.1186/s12879-014-0651-8
pubmed: 25487053
pmcid: 4264321
Zhang X, Jiang S, Zhou X, Yu Z, Han S, Nan F, Qiao H, Niu D, Wang Z, Niu J, Zhang H, Liu T, Wang Y, Wang B. Human cytomegalovirus-IE2 affects embryonic liver development and survival in transgenic mouse. Cell Mol Gastroenterol Hepatol. 2022;14(2):494–511.
doi: 10.1016/j.jcmgh.2022.05.002
pubmed: 35569816
pmcid: 9305021
Hu J, Zhao H, Lou D, Gao H, Yang M, Zhang X, et al. Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure. BMC Infect Dis. 2018;18(1):577.
doi: 10.1186/s12879-018-3488-8
pubmed: 30445927
pmcid: 6240234
Üstündağ H, Danişman Kalindemirtaş F, Doğanay S, Demir Ö, Kurt N, Tahir Huyut M, Özgeriş B, Kariper İA. Enhanced efficacy of resveratrol loaded silver nanoparticle in attenuating sepsis-induced acute liver injury: modulation of inflammation, oxidative stress, and SIRT1 activation. Shock. 2023. https://doi.org/10.1097/SHK.0000000000002218
Liu A, Wang W, Fang H, Yang Y, Jiang X, Liu S, et al. Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice. Eur J Pharmacol. 2015;748:45–53.
doi: 10.1016/j.ejphar.2014.12.014
pubmed: 25533331
Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang W, Brashear W, Dai Y, Li S, Sun Y, Qi Y, Guo S. Hepatocyte FoxO1 deficiency protects from liver fibrosis via reducing inflammation and TGF-β1 mediated HSC activation. Cell Mol Gastroenterol Hepatol. 2023:S2352–345X(23)00161–3. https://doi.org/10.1016/j.jcmgh.2023.08.013 .
Jamann H, Desu HL, Cui QL, Halaweh A, Tastet O, Klement W, Zandee S, Pernin F, Mamane VH, Ouédraogo O, Daigneault A, Sidibé H, Millette F, Peelen E, Dhaeze T, Hoornaert C, Rébillard RM, Thai K, Grasmuck C, Vande Velde C, Prat A, Arbour N, Stratton JA, Antel J, Larochelle C. Activated leukocyte cell adhesion molecule on human oligodendrocytes mediates CD4 T cell adhesion. Brain. 2023:awad286. https://doi.org/10.1093/brain/awad286 .
Nakajima K, Hiejima E, Nihira H, Kato K, Honda Y, Izawa K, Kawabata N, Kato I, Ogawa E, Sonoda M, Okamoto T, Okajima H, Yasumi T, Takita J. Case report: a case of Epstein-Barr virus-associated acute liver failure requiring hematopoietic cell transplantation after emergent liver transplantation. Front Immunol. 2022;13:825806.
doi: 10.3389/fimmu.2022.825806
pubmed: 35154146
pmcid: 8834065